Kathmere Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-176	Closed	-$11K	–	290
2020 Q4	$11K	Hold	176	–	–	﹤0.01%	315
2020 Q3	$10K	Buy	+176	New	+$10K	﹤0.01%	301